🇬🇧 United Kingdom Country × Condition
hypertension Clinical Trials in United Kingdom
Active clinical trials for hypertension with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (4)
NCT02132741
Recruiting
Optical Coherence Tomography And NEphropathy: The OCTANE Study
Enrollment
150 pts
Country
🇬🇧 United Kingdom
University of Edinburgh
View Trial → NCT07364175
Recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Enrollment
60 pts
Country
🇬🇧 United Kingdom
Cambridge University Hospitals NHS ...
View Trial → NCT06670677
Recruiting
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
Enrollment
15,000 pts
Country
🇬🇧 United Kingdom
Aktiia SA
View Trial → NCT07758634 Phase 1, Phase 2
Recruiting
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Enrollment
69 pts
Country
🇬🇧 United Kingdom
CRISPR Therapeutics AG
View Trial → Frequently Asked Questions
How many hypertension clinical trials are active in United Kingdom?
There are currently 4 active clinical trials for hypertension with sites in United Kingdom, of which 4 are actively recruiting patients.
How can I join a hypertension clinical trial in United Kingdom?
To join a hypertension clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hypertension trials in United Kingdom?
Active hypertension trials in United Kingdom span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology